Mereo BioPharma Group Stock (NASDAQ: MREO) stock price, news, charts, stock research, profile.
You can purchase shares of Mereo BioPharma Group (NASDAQ:MREO) through any online brokerage.
Other companies in Mereo BioPharma Group’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and Pharming (NASDAQ:PHAR).
Mereo BioPharma Group has a consensus price target of $6.80.
The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $3.54 last updated November 15, 2024 at 4:47 PM EST.
There are no upcoming dividends for Mereo BioPharma Group.
Mereo BioPharma Group’s Q4 earnings are confirmed for Thursday, February 13, 2025.
There is no upcoming split for Mereo BioPharma Group.
Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.